Great call the action is very exciting today and looks like it has quite a runway until it pauses. Finally there is some alignment between the potential and reality for RSH in the US. No question the devastating impact of COVID on a failing US healthcare and hospital system has scared the living daylights out of Insurers, Employers and Govt. agencies like Medicare and Medicaid. So any company that is part of the solution in reducing hospitalization, emergency & doctor visits, overall health care costs, improved compliance with medication will be welcomed with open arms. If the results of the recent study are half true then the risk benefit ratio of RPM is enormous and will be adopted as best practice across the country. This is only the tip of the iceberg !!
RSH Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)